Advertisement

Topics

Illumina Company Profile

15:23 EST 15th December 2018 | BioPortfolio

Illumina develops tools for the large-scale analysis of genetic variation and function, the results of which will pave the way for personalized medicine, a key goal of genomics and proteomics. Our technology platform also extends to other applications such as high-throughput screening of pharmaceutical compounds and chemical detection.

Location

9390 Towne Centre Dr. Suite 200
San Diego
CA
92024
United States of America

Contact

Phone: 858 587 4297
Email: investor@illumina.com


News Articles [90 Associated News Articles listed on BioPortfolio]

Illumina: Profiteur des Diagnostik-Booms

Kulmbach (www.aktiencheck.de) - Illumina-Aktienanalyse von "Der Aktionär": Michel Doepke, Redakteur des Anlegermagazins "Der Aktionär", nimmt in einer aktuellen Aktienanalyse die Aktie von Illumina....

Illumina-Aktie: Neues Rekordhoch markiert

Kulmbach (www.aktiencheck.de) - Illumina-Aktienanalyse von "Der Aktionär": Michel Doepke, Redakteur des Anlegermagazins "Der Aktionär", nimmt in einer aktuellen Aktienanalyse die Illumina-Aktie (IS....

Illumina -- LATEST 1

BIO's preferred Gene Sequencing Solutions provider, Illumina, offers a free learning opportunity with a recorded webinar, "Th -More- 

Pacific Biosciences rockets after DNA sequencing giant Illumina buys it for $1.2 billion

Illumina needs a technology like Pac Bio to increase their capabilities and stay dominant

Illumina to buy Pacific Biosciences for $1.2 billion

The $8 per share deal will allow Illumina to tap into the long-read sequencing market, while also heading off competition from other firms, analyst writes.

Illumina Set to Acquire “Long-Read” DNA Sequencer PacBio for $1.2B

DNA sequencing giant Illumina is shoring up its position in genetic research through a cash deal to acquire Pacific Biosciences for approximately $1.2 billion. Under the agreement, Illumina (NASDAQ: I...

Illumina Inc. Q2 adjusted earnings Beat Estimates

SAN DIEGO (dpa-AFX) - Illumina Inc. (ILMN) announced a profit for its second quarter that advanced from the same period last year.The company's bottom line totaled $209 million, or $1.41 per share...

Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion

Illumina, Inc. and Pacific Biosciences announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction....

Drugs and Medications [0 Results]

None

PubMed Articles [50 Associated PubMed Articles listed on BioPortfolio]

Analysis of Sulfate-Reducing and Sulfur-Oxidizing Prokaryote Community Structures in Marine Sediments with Different Sequencing Technologies.

Sulfate-reducing prokaryotes (SRP) and sulfur-oxidizing prokaryotes (SOP) play vital roles in the sulfur cycle. The SRP community was used to represent a microbial community with high richness and div...

Simulating Illumina Metagenomic Data with InSilicoSeq.

The accurate in-silico simulation of metagenomic datasets is of great importance for benchmarking bioinformatics tools as well as for experimental design. Users are dependant on large-scale simulation...

Correction: Microbial diversity in two traditional bacterial douchi from Gansu province in northwest China using Illumina sequencing.

[This corrects the article DOI: 10.1371/journal.pone.0194876.].

Long-range PCR and high-throughput sequencing of Ostreid herpesvirus 1 indicate high genetic diversity and complex evolution process.

Ostreid herpesvirus 1 (OsHV-1) is an important pathogen associated with mass mortalities of cultivated marine mollusks worldwide. Since no cell line allows OsHV-1 replication in vitro, it is difficult...

Transcriptome Comparative Analysis of Salt Stress Responsiveness in Chrysanthemum (Dendranthema grandiflorum) Roots by Illumina- and Single-Molecule Real-Time-Based RNA Sequencing.

Salt response has long been considered a polygenic-controlled character in plants. Under salt stress conditions, plants respond by activating a great amount of proteins and enzymes. To develop a bette...

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

The ILLUMINA Study. (ILLUMINA)

The aim of the prospective, multicentre, single-arm study is to assess safety and efficacy of a drug eluting stent in Nitinol alloy (NiTiDES) in term of vessel patency and composite event-...

Effect of Probiotics on Nasopharyngeal Microbiome of Children With Otitis Media With Effusion

The aim of this study is to investigate whether the microbiota in the upper respiratory tract (nasopharynx, adenoids and middle ear fluid) of otitis media with effusion (OME) patients is c...

Epigenetic Biomarker for Osteosarcoma

hMe-Seal is a low-input whole-genome cell-free 5hmC sequencing method based on selective chemical labeling. It uses β-glucosyltransferase (βGT) to selectively label 5hmC with a biotin vi...

Comprehensive DNA Methylation Profiling in Crohn's Disease

Previous studies have indicated that abnormal DNA methylation frequently occurs in the mucosa in Crohn's disease. Comprehensive DNA methylation profiling of the inflamed and non-inflamed i...

Nutritional Intake and Gut Microbiome

Pediatric obesity has been increasing in prevalence, but concerns have been raised around the world because no treatment has been found. Recently, however, research on gut microbiome has b...

Companies [14 Associated Companies listed on BioPortfolio]

Illumina

Illumina develops tools for the large-scale analysis of genetic variation and function, the results of which will pave the way for personalized medicine, a key goal of genomics and proteomics. Our tec...

Illumina Inc.

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and functi...

GRAIL

GRAIL is focused on detecting cancer at an early-stage, when it can be cured. The company secured over $100 million in Series A financing from Illumina, Inc. and ARCH Venture Part...

Illumina, Inc.

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and ...

bioMérieux & Illumina

More Information about "Illumina" on BioPortfolio

We have published hundreds of Illumina news stories on BioPortfolio along with dozens of Illumina Clinical Trials and PubMed Articles about Illumina for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Illumina Companies in our database. You can also find out about relevant Illumina Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record